Pharmacology, Toxicology and Pharmaceutical Science
IC50
100%
Glucosidase
48%
Koji
35%
Urease
26%
Structure Activity Relationship
25%
Acarbose
22%
Imine
21%
Oxadiazole Derivative
17%
Acetylcholinesterase
16%
Urease Inhibitor
14%
Thiadiazoles
14%
Indole
13%
Carbon 13
13%
Thiourea
12%
Benzimidazole
12%
Beta Glucuronidase
11%
Diabetes Mellitus
11%
Sulfonamide
9%
Antidiabetic Agent
9%
Thiazole
9%
1,1 Diphenyl 2 Picrylhydrazyl
9%
Alzheimer's Disease
9%
Amylase Inhibitor
9%
Thymidine Phosphorylase
8%
ABTS
8%
Absorption Distribution Metabolism Excretion
7%
Cytotoxicity
6%
Antioxidant
6%
Benzofuran
6%
Cholinesterase Inhibitor
5%
Benzimidazole Derivative
5%
Donepezil
5%
Enzyme Inhibition
5%
Chemistry
IC50
61%
Molecular Docking
42%
Glucosidase
30%
Amylase
21%
Acarbose
14%
Thiadiazole
13%
Butyrylcholinesterase
12%
Structure-Activity Relationship
12%
Oxadiazole
11%
1H NMR Spectroscopy
10%
13C NMR Spectroscopy
10%
Imine
10%
Amylase Inhibitor
8%
Kinetic Study
8%
Antioxidant Agent
8%
Benzimidazole
7%
Indole
7%
Antidiabetic Agent
6%
Antioxidant Capacity
6%
Anti Alzheimer
6%
urease inhibitor
6%
Sulfonamide
5%
Thiourea
5%
Thiazole
5%
Biochemistry, Genetics and Molecular Biology
IC50
38%
Docking (Molecular)
33%
Glucosidase
28%
Koji
28%
Enzyme
20%
Acarbose
10%
Structure Activity Relation
9%
In Silico Study
7%
Thymidine Phosphorylase
7%
Thiadiazoles
7%
Active Site
6%
Thiazole
6%
Acetylcholinesterase
5%
Sulfonamide
5%